Coronapod: solving the COVID vaccine manufacturing problem
Nature Podcast
00:00
Is Quality Control the Complete Barrier?
Madurna and feiser are on tract to bring in more than 53 billion in revenue this year just from the coved vaccines. They're hopeful that m r and a vaccines can be a platform to make vaccines for all sorts of things like cancer and h i v. So therefore, teaching another company how to make an mrnavaccine compromises their hold on the field. None of the companies i spoke to said, this is why. But this is something that people, you know, point out pretty easily.
Transcript
Play full episode
